Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8416502rdf:typepubmed:Citationlld:pubmed
pubmed-article:8416502lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:8416502lifeskim:mentionsumls-concept:C0271429lld:lifeskim
pubmed-article:8416502lifeskim:mentionsumls-concept:C0007561lld:lifeskim
pubmed-article:8416502lifeskim:mentionsumls-concept:C0442117lld:lifeskim
pubmed-article:8416502pubmed:issue1lld:pubmed
pubmed-article:8416502pubmed:dateCreated1993-1-21lld:pubmed
pubmed-article:8416502pubmed:abstractTextThis study evaluated the efficacy of a single dose of intramuscular ceftriaxone for acute otitis media in children, using amoxicillin as a control. (There is currently no established single-dose treatment for this condition.) In a prospective, randomized, double-blind, clinical trial, 233 children, aged 5 months to 5 years, with uncomplicated acute otitis media were randomly assigned to receive either a single intramuscular injection of ceftriaxone (50 mg/kg) plus placebo oral suspension for 10 days, or a placebo injection plus amoxicillin oral suspension (40 mg/kg per day divided three times per day) for 10 days in a double-blind fashion. Demographic and clinical characteristics were similar in both groups. Treatment was successful in 107 of 117 given amoxicillin (91%, 95% confidence interval 86% to 97%) and 105 of 116 given ceftriaxone (91%, 95% confidence interval 85% to 96%). Rates of improvement, failure, relapse, and reinfection were similar in both groups, as were the otoscopic and tympanometric evaluations at the 14- and 60-day follow-up visits. It is concluded that a single intramuscular injection of ceftriaxone (50 mg/kg) is as effective as 10 days of oral amoxicillin for the treatment of uncomplicated acute otitis media in children.lld:pubmed
pubmed-article:8416502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8416502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8416502pubmed:languageenglld:pubmed
pubmed-article:8416502pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8416502pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8416502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8416502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8416502pubmed:statusMEDLINElld:pubmed
pubmed-article:8416502pubmed:monthJanlld:pubmed
pubmed-article:8416502pubmed:issn0031-4005lld:pubmed
pubmed-article:8416502pubmed:authorpubmed-author:GreenS MSMlld:pubmed
pubmed-article:8416502pubmed:authorpubmed-author:RothrockS GSGlld:pubmed
pubmed-article:8416502pubmed:issnTypePrintlld:pubmed
pubmed-article:8416502pubmed:volume91lld:pubmed
pubmed-article:8416502pubmed:ownerNLMlld:pubmed
pubmed-article:8416502pubmed:authorsCompleteYlld:pubmed
pubmed-article:8416502pubmed:pagination23-30lld:pubmed
pubmed-article:8416502pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:meshHeadingpubmed-meshheading:8416502-...lld:pubmed
pubmed-article:8416502pubmed:year1993lld:pubmed
pubmed-article:8416502pubmed:articleTitleSingle-dose intramuscular ceftriaxone for acute otitis media in children.lld:pubmed
pubmed-article:8416502pubmed:affiliationDept of Emergency Medicine, Riverside General Hospital, CA 92503.lld:pubmed
pubmed-article:8416502pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8416502pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8416502pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8416502pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8416502pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8416502lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8416502lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8416502lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8416502lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8416502lld:pubmed